After roughly four hours with the first four chapters on PC, Fatal Frame 2: Crimson Butterfly Remake already has its hooks in ...

Recursion Pharmaceuticals (RXRX) shares recently closed at US$3.98, with the stock showing a negative return over the past month and past 3 months, which may prompt investors to reassess its current ...

Earlier in January, Recursion Pharmaceuticals updated investors at the JP Morgan Healthcare Conference on its AI-powered drug discovery platform, clinical programs, and collaborations with partners ...

The funding discussions highlight ongoing investor demand for new and unproven research labs looking to find novel approaches to AI that push the technology forward. Recursive’s goal is to develop ...

TVs tend to stick out in our living rooms, and when they're turned off, they're basically just big black rectangles staring back at us. Not exactly décor-friendly. That's the problem Samsung set out ...

Ricursive Intelligence, a startup building an AI system to design and automatically improve AI chips, has raised $300 million at a $4 billion valuation. The company said Monday the round was led by ...

It's been years since Valve first launched its in-house VR headset, the Valve Index, back in 2019, but the Steam owner has spent the time well developing its new Steam Frame. This standalone headset ...

VR gamers are patiently awaiting the next generation of headsets, as the Steam Frame is on the way. Unfortunately, it isn’t arriving in “early 2026” as planned. We’re going through the expected Steam ...

“Sweet dreams” is a nice sentiment, but when you’re tossing and turning on creaky wooden slats, those dreams aren’t so sweet. The best bed frames stay sturdy and silent, no matter how much you move, ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...